Stoke Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

by Business Wire • 2022/04/05 • 0 Comments

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022, at 8:00 a.m. ET. A live webcast of the presentation, which will be conducted in fireside chat format, will be available on the Investors & New

← Worldwide Phoropters Industry to 2027 – Specialty Clinics Hold a Significant Share in the Market – ResearchAndMarkets.com

Aldeyra Therapeutics Announces Completion of Enrollment in Phase 3 TRANQUILITY-2 Trial in Patients with Dry Eye Disease →

Post navigation